Testing its multiple supports placed around Rs.684 (38.2% FR, dual moving averages), should give a bounce to at-least 751. Above 751, it can then retest the high of 793.
Close below 582, TGT 555. SL 587(Closing Basis)
Disclaimer: I am a novice at charting and the chart is only for educational purpose. Views and opinions are welcome.
Fundamentals-
1)Excellent company in Pharma space.
2)Good earnings.
3)Operating profit, sales, growth are consistent and > 20%
Key note--> Every dip is the opportunity to accumulate this stock
CMP-671(22nd Feb'2017)
1st target-850+(6 months)
Disclaimer : I am a private trader who is just expressing his views. These are just my opinions and i am not giving any...
Auro Pharma is bearish counter, this stock is trading with in the Big Candle
It is giving response to the supply line. so it will go up to big candle low.
if it is close below this low 698 break if this candle, heavy selling may be seen in this counter.
next target is swing low 615 is possible.
wish u happy trading and enjoy this trade
The price action is forming new highs and higher lows for a while that indicates buyers dominance which is taking up the prices higher. Now, I believe the prices shall reach to previous high at 888 or the resistance where sellers might enter into markets again and then the fight of dominance shall shuffle.
TargetL 888
Stoploss:836
Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It is also developing inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI). It markets its products through chain stores in the United States. It has developed over three injectable penem products. The Company, through its subsidiary, manufactures and sells nutritional supplements. It has over 10 manufacturing units and approximately two research and development centers. The Company, in addition to marketing its products domestically, also markets its products globally in over 150 countries.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
AUROPHARMA
